ES8200920A1 - Procedimiento de preparacion de una nueva substancia a par- tir de celulas aisladas del cultivo de micrococcus sedogen- tes m 78 - Google Patents

Procedimiento de preparacion de una nueva substancia a par- tir de celulas aisladas del cultivo de micrococcus sedogen- tes m 78

Info

Publication number
ES8200920A1
ES8200920A1 ES490702A ES490702A ES8200920A1 ES 8200920 A1 ES8200920 A1 ES 8200920A1 ES 490702 A ES490702 A ES 490702A ES 490702 A ES490702 A ES 490702A ES 8200920 A1 ES8200920 A1 ES 8200920A1
Authority
ES
Spain
Prior art keywords
isolated
preparation
active substance
biologically active
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES490702A
Other languages
English (en)
Other versions
ES490702A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Industries SA
Original Assignee
Rhone Poulenc Industries SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Industries SA filed Critical Rhone Poulenc Industries SA
Publication of ES8200920A1 publication Critical patent/ES8200920A1/es
Publication of ES490702A0 publication Critical patent/ES490702A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/05—Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/265—Micrococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/859—Micrococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE LA SUSTANCIA 41.200 RP A PARTIR DE CELULAS AISLADAS DE CULTIVO DE MICROCOCCUS SEDOGENES M.78. CONSISTE EN TRATAR CON LIXOZIMA A UN PH COMPRENDIDO ENTRE 6,5 Y 8 DURANTE UN TIEMPO DE UNA A TRES HORAS, A UNA TEMPERATURA PROXIMA A 37 C., UNA SUSPENSION ACUOSA DE CELULAS DE MIROCOCCUS SEDOGENES, CEPA M. 78; EL PRODUCTO SE AISLA EN FORMA SALIFICADA DE LA FASE LIQUIDA DE LA SUPENSION OBTENIDA Y SE PURIFICA POR TRATAMIENTO AL CLORURO DE CALCIO PARA OBTENER UNA SUSTANCIA DESIGNADA COMO 32919 RP, LA CUAL SE PURIFICA POR TRATAMIENTO DE SU SOLUCION ACUOSA POR FENOL SEGUIDO DEL FRACCIONAMIENTO SOBRE TAMIZ MOLECULAR RECOGIENDO LA FRACCION DE ALTO PESO MOLECULAR DE LA QUE SE AISLA LA 41.200 RP, LA CUAL CONTIENE CIDOS AMINADOS, GLUCOSA, AZUCARES AMINADOS Y ACIDOS NUCLEICOS.
ES490702A 1979-04-18 1980-04-18 Procedimiento de preparacion de una nueva substancia a par- tir de celulas aisladas del cultivo de micrococcus sedogen- tes m 78 Granted ES490702A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7909743A FR2454302A1 (fr) 1979-04-18 1979-04-18 Nouvelle substance biologiquement active, sa preparation et les medicaments qui la contiennent

Publications (2)

Publication Number Publication Date
ES8200920A1 true ES8200920A1 (es) 1981-11-16
ES490702A0 ES490702A0 (es) 1981-11-16

Family

ID=9224428

Family Applications (1)

Application Number Title Priority Date Filing Date
ES490702A Granted ES490702A0 (es) 1979-04-18 1980-04-18 Procedimiento de preparacion de una nueva substancia a par- tir de celulas aisladas del cultivo de micrococcus sedogen- tes m 78

Country Status (26)

Country Link
US (1) US4313936A (es)
JP (1) JPS5611795A (es)
AT (1) AT370129B (es)
AU (1) AU538492B2 (es)
BE (1) BE882841A (es)
CA (1) CA1122526A (es)
CH (1) CH646873A5 (es)
DE (1) DE3015030A1 (es)
DK (1) DK163980A (es)
ES (1) ES490702A0 (es)
FI (1) FI67571C (es)
FR (1) FR2454302A1 (es)
GB (1) GB2046759B (es)
GR (1) GR66676B (es)
HU (1) HU181104B (es)
IE (1) IE49446B1 (es)
IL (1) IL59842A (es)
IT (1) IT1209323B (es)
LU (1) LU82370A1 (es)
NL (1) NL8002108A (es)
NO (1) NO155103C (es)
NZ (1) NZ193457A (es)
PT (1) PT71107A (es)
SE (1) SE446344B (es)
SU (1) SU1042602A3 (es)
ZA (1) ZA802271B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2522945B2 (ja) * 1987-06-18 1996-08-07 呉羽化学工業株式会社 抗レトロウィルス剤
CH680192A5 (es) * 1989-12-13 1992-07-15 Nestle Sa
AU6838996A (en) * 1996-05-27 1998-01-05 Alexei Nikolaevich Parfenov Use of streptococcus faecium strains and composition containing the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1547388A (fr) * 1967-02-22 1968-11-29 Rhone Poulenc Sa Nouvel antibiotique et sa préparation par culture d'un streptomyces
US4174390A (en) * 1977-02-07 1979-11-13 Eli Lilly And Company Antibiotic A-7413 and process for preparation thereof
US4180565A (en) * 1978-05-25 1979-12-25 Schering Corporation 1-N-substituted derivatives of 4,6-di-O-(aminoglycosyl)-1,3-diaminocyclitols

Also Published As

Publication number Publication date
NO155103C (no) 1987-02-11
JPS5611795A (en) 1981-02-05
FR2454302B1 (es) 1982-05-21
NZ193457A (en) 1983-02-15
IT1209323B (it) 1989-07-16
SE8002898L (sv) 1980-10-19
LU82370A1 (fr) 1980-12-16
GB2046759B (en) 1983-02-23
DK163980A (da) 1980-10-19
CA1122526A (fr) 1982-04-27
GB2046759A (en) 1980-11-19
CH646873A5 (fr) 1984-12-28
BE882841A (fr) 1980-10-17
GR66676B (es) 1981-04-08
PT71107A (fr) 1980-05-01
DE3015030C2 (es) 1988-09-08
IT8021495A0 (it) 1980-04-18
IL59842A (en) 1984-02-29
ATA205480A (de) 1982-07-15
DE3015030A1 (de) 1981-05-07
ZA802271B (en) 1981-04-29
AU5749480A (en) 1980-10-23
IE800772L (en) 1980-10-18
SE446344B (sv) 1986-09-01
FI67571B (fi) 1984-12-31
US4313936A (en) 1982-02-02
FI67571C (fi) 1985-04-10
JPS6251275B2 (es) 1987-10-29
NO155103B (no) 1986-11-03
NL8002108A (nl) 1980-10-21
IE49446B1 (en) 1985-10-02
FI801251A7 (fi) 1980-10-19
SU1042602A3 (ru) 1983-09-15
IL59842A0 (en) 1980-06-30
AU538492B2 (en) 1984-08-16
FR2454302A1 (fr) 1980-11-14
HU181104B (en) 1983-06-28
ES490702A0 (es) 1981-11-16
NO801114L (no) 1980-10-20
AT370129B (de) 1983-03-10

Similar Documents

Publication Publication Date Title
DK130883D0 (da) Fremgangsmade til fremstilling af terapeutiske eller diagnostiske praeparater
FR2457281A1 (fr) Nouveaux derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee
ES8505405A1 (es) Un procedimiento para producir un activador de plasminogeno purificado.
ES2078570T3 (es) Derivados de n-acil-alfa-aminoacidos.
IT8420940A1 (it) Sali stabili della solfo-adenosil-L-metionina (saMe; particolarmente idonei per uso farmaceutico orale
ES8102804A1 (es) Un metodo para preparar compuestos utiles como precursores de aminoacidos esenciales y semiesenciales
Rothschild Sea‐urchin spermatozoa
EP0095682A2 (de) Verfahren zur Herstellung zell- und geweberegenerierender Stoffe
ATE120485T1 (de) Bioreaktor.
ES2066237T3 (es) Procedimiento para producir gamma-interferon humano recombinante sin cisteina carente de metionina en el extremo n-terminal.
ES8200920A1 (es) Procedimiento de preparacion de una nueva substancia a par- tir de celulas aisladas del cultivo de micrococcus sedogen- tes m 78
EP0245669A3 (en) Pharmaceutical preparation for preventing damage to living cells by free radicals, or for increasing the efficacy of organic sulphur compounds, and process for increasing the life span of isolated organs
ES462861A1 (es) Un metodo para la produccion de dextrosa en polvo.
SE7706425L (sv) Forfarande for framstellning av polyribonukleotider med aktivitet vid alstrandet av leukocyter och blodplettar
GB1220770A (en) Process for the purification of lactic acid
ES2057762T3 (es) Composicion de caucho de silicona y su fabricacion.
ES8105034A1 (es) Procedimiento para la produccion de una istamicina
Menkin Studies on inflammation: Xvi. On the formation of a chemotactic substance by enzymatic action
ATE7202T1 (de) Nichtadsorbierbare, mukolytische verbindungen, verfahren zu ihrer herstellung und therapeutische zusammensetzungen, die diese verbindungen als wirkstoff enthalten.
JPS56156211A (en) Preparation of stable allantoin pharmaceutical
JPS5381691A (en) Preparation of l-serine
SE7907986L (sv) Sett att framstella 3alfa,7beta-dihydroxicholansyra
ATE4216T1 (de) 3-hydrocarbylthio-2-acyloxypropyl 2trimethylammonioethyl phosphate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
FR2322544A1 (fr) Degagement de l'ethylene dans les plantes, par un melange ameliore contenant de l'acide 2-chloro-ethylphosphonique
ES2028183T3 (es) Procedimiento para la obtencion d- o l-alanina con elevada pureza en enantiomeros.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303